• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21.

作者信息

Ma G-C, Wu W-J, Lee M-H, Lin Y-S, Chen M

机构信息

Department of Genomic Medicine and Center for Medical Genetics, Changhua Christian Hospital, Changhua, Taiwan.

Department of Genomic Science and Technology, Changhua Christian Hospital Healthcare System, Changhua, Taiwan.

出版信息

Ultrasound Obstet Gynecol. 2018 Feb;51(2):276-277. doi: 10.1002/uog.17473.

DOI:10.1002/uog.17473
PMID:28337808
Abstract
摘要

相似文献

1
Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21.低分子量肝素与胎儿游离DNA比例降低及随后21三体游离DNA检测结果假阴性有关。
Ultrasound Obstet Gynecol. 2018 Feb;51(2):276-277. doi: 10.1002/uog.17473.
2
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
3
Re: Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false- negative cell-free DNA test result for trisomy 21.关于：低分子量肝素与胎儿游离DNA比例降低及随后21三体综合征游离DNA检测结果假阴性相关。
Ultrasound Obstet Gynecol. 2018 Feb;51(2):278. doi: 10.1002/uog.18984.
4
First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.早孕期基于超声和游离 DNA 检测与联合筛查的风险评估：一项随机对照试验。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):437-444. doi: 10.1002/uog.18905. Epub 2018 Mar 4.
5
Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.对孕中期唐氏综合征和18三体血清筛查的敏感性和假阳性率的估计，并对交叉识别和双阳性结果进行了调整。
Prenat Diagn. 2001 Jan;21(1):46-51.
6
Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?低分子量肝素用于复发性流产：是否有确凿证据支持？
J Thromb Haemost. 2005 Feb;3(2):221-3. doi: 10.1111/j.1538-7836.2005.01155.x.
7
A unified approach to risk assessment for fetal aneuploidies.胎儿非整倍体风险评估的统一方法。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):48-54. doi: 10.1002/uog.14694. Epub 2014 Dec 1.
8
The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing Platform.IONA®检测：开发一种基于游离DNA的自动化筛查检测方法，用于检测胎儿13、18和21三体综合征，该方法采用Ion Proton半导体测序平台。
Fetal Diagn Ther. 2017;42(3):218-224. doi: 10.1159/000455025. Epub 2017 Feb 8.
9
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial.低分子量肝素与阿司匹林治疗复发性流产：HepASA试验结果
J Rheumatol. 2010 Jan;37(1):202; author reply 203. doi: 10.3899/jrheum.090310.
10
The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.游离循环肿瘤 DNA 与无创性产前检测结果联合应用于乳腺癌的模拟研究
DNA Cell Biol. 2018 Jul;37(7):626-633. doi: 10.1089/dna.2017.4112. Epub 2018 Jun 29.

引用本文的文献

1
The Art (and Science) of Individualized Selection of Non-Invasive Prenatal Screening (NIPS).非侵入性产前筛查（NIPS）个体化选择的艺术（与科学）
Int J Womens Health. 2025 May 7;17:1271-1283. doi: 10.2147/IJWH.S437214. eCollection 2025.
2
Factors, pregnancy outcomes, and management associated with non-reportable results in prenatal cell-free DNA testing.与产前游离DNA检测不可报告结果相关的因素、妊娠结局及管理
Arch Gynecol Obstet. 2025 Feb 18. doi: 10.1007/s00404-025-07977-w.
3
The Effect of Self-Reported Race on Noninvasive Prenatal Screening Test Characteristics.
自我报告的种族对无创产前筛查测试特征的影响。
Am J Perinatol. 2025 Jan;42(1):6-13. doi: 10.1055/s-0044-1789573. Epub 2024 Aug 29.
4
The Association between Low Fetal Fraction of Non-Invasive Prenatal Testing and Adverse Pregnancy Outcomes for Placental Compromise.无创产前检测低胎儿游离DNA比例与胎盘功能不全不良妊娠结局的关联
Diagnostics (Basel). 2024 May 15;14(10):1020. doi: 10.3390/diagnostics14101020.
5
Anticoagulation use is associated with lower fetal fraction and more indeterminate results.抗凝治疗的使用与较低的胎儿分数和更多不确定的结果有关。
Am J Obstet Gynecol. 2024 Jan;230(1):95.e1-95.e10. doi: 10.1016/j.ajog.2023.07.005. Epub 2023 Jul 8.
6
Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.基于机器学习从全基因组游离DNA测序数据集中检测免疫介导疾病
NPJ Genom Med. 2022 Sep 14;7(1):55. doi: 10.1038/s41525-022-00325-w.
7
The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures.丙氨酸转氨酶升高对无创产前筛查失败的影响。
Front Med (Lausanne). 2022 Jun 15;9:875588. doi: 10.3389/fmed.2022.875588. eCollection 2022.
8
Follow-up in Patients With Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis.无创产前筛查失败患者的随访：关于进一步产前诊断选择的思考
Front Genet. 2021 May 19;12:666648. doi: 10.3389/fgene.2021.666648. eCollection 2021.
9
Fetal fraction and noninvasive prenatal testing: What clinicians need to know.胎儿比例与无创性产前检测：临床医生须知。
Prenat Diagn. 2020 Jan;40(2):155-163. doi: 10.1002/pd.5620. Epub 2019 Dec 10.
10
A Silicon-based Coral-like Nanostructured Microfluidics to Isolate Rare Cells in Human Circulation: Validation by SK-BR-3 Cancer Cell Line and Its Utility in Circulating Fetal Nucleated Red Blood Cells.一种用于分离人体循环中稀有细胞的硅基珊瑚状纳米结构微流控技术：通过SK-BR-3癌细胞系验证及其在循环胎儿有核红细胞中的应用
Micromachines (Basel). 2019 Feb 17;10(2):132. doi: 10.3390/mi10020132.